D-Allose has a strong suppressive effect against ischemia/reperfusion injury: a comparative study with allopurinol and superoxide dismutase

被引:51
作者
Hossain, MA
Izuishi, K
Tokuda, M
Izumori, K
Maeta, H
机构
[1] Kagawa Med Univ, Dept Surg 1, Kagawa 7610793, Japan
[2] Kagawa Ind Support Fdn, Kagawa, Japan
[3] Kagawa Med Univ, Dept Cell Physiol, Kagawa, Japan
[4] Kagawa Univ, Fac Agr, Dept Biochem & Food Sci, Kagawa, Japan
来源
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY | 2004年 / 11卷 / 03期
关键词
D-allose; allopurinol; SOD; liver ischemia; reperfusion injury;
D O I
10.1007/s00534-003-0892-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Purpose. D-Allose, a rare sugar, is one of the potent inhibitors of ischemia/reperfusion injury of the rat liver. To investigate the potency of this powerful agent we examined its effect against ischemia/reperfusion injury and compared it to that of allopurinol and superoxide dismutase. Methods. Male Lewis rats were given water ad libitum preoperatively for 12h and anesthetized by isoflurane inhalation anesthesia. Drugs were administered through a polyethylene catheter inserted into the portal vein for 2h (D-allose), 10 min (allopurinol), or 5 min (superoxide dismutase) before ischemia, and the livers were then subjected to 70% ischemia, induced by crossclamping the vessels to the lateral and median lobes of the liver for 90 min. Rats were divided into four groups: group 1, pretreated with vehicle (normal saline); group 2, treated with D-allose; group 3, treated with allopurinol; and group 4, treated with superoxide dismutase. The effects of the drugs were evaluated by liver hemodynamics, neutrophil count, myeloperoxidase, liver enzymes, and histological studies. Results. D-Allose improved liver hemodynamics (P < 0.001) and postischemic animal survival (P < 0.05) significantly compared with the control group and nonsignificantly compared with the allopurinol and superoxide dismutase groups. Myeloperoxidase activity in the postischemic liver tissue was decreased significantly (P < 0.05) by D-allose compared with all other treatment and control groups. Neutrophil count was also significantly (P < 0.05) decreased in the D-allose group compared with than that in the control group, as well as the superoxide dismutase group. Only D-allose produced a statistically significant decrease in the level of liver enzymes, compared with levels in the control group. Conclusions. The moderately protective effect of D-allose which caused no clinical side effects, is encouraging. D-Allose had the best protective effect against neutrophil-related postischemic injury of the liver tissue, followed by allopurinol and superoxide dismutase. However, a more extensive study is needed to ensure the effects as well as the mechanisms of the effect of this rare sugar.
引用
收藏
页码:181 / 189
页数:9
相关论文
共 33 条
[1]   INFLUENCE OF OXYGEN-DERIVED FREE-RADICAL SCAVENGERS ON ISCHEMIC LIVERS [J].
ATALLA, SL ;
TOLEDOPEREYRA, LH ;
MACKENZIE, GH ;
CEDERNA, JP .
TRANSPLANTATION, 1985, 40 (06) :584-590
[2]   D-allose production from D-psicose using immobilized L-rhamnose isomerase [J].
Bhuiyan, SH ;
Itami, Y ;
Rokui, Y ;
Katayama, T ;
Izumori, K .
JOURNAL OF FERMENTATION AND BIOENGINEERING, 1998, 85 (05) :539-541
[3]   THE EFFECTS OF LONG-TERM GRAFT PRESERVATION AND PROSTAGLANDIN-E1 ON INTRAOPERATIVE HEMODYNAMIC-CHANGES IN LIVER-TRANSPLANTATION - A COMPARISON BETWEEN ORTHOTOPIC AND HETEROTOPIC TRANSPLANTATION IN THE PIG [J].
BLANKENSTEIJN, JD ;
SCHLEJEN, PM ;
GROENLAND, THN ;
TERPSTRA, OT .
TRANSPLANTATION, 1992, 54 (03) :423-428
[4]  
Chavez Cartaya R, 1999, TRANSPL INT, V12, P213
[5]   Neutrophil elastase inhibitor (ONO-5046) attenuates reperfusion-induced hepatic microcirculatory derangement, energy depletion and lipid peroxidation in rats [J].
Chen, HM ;
Chen, JC ;
Shyr, MH ;
Chen, MF ;
Hwang, TL ;
Fan, LL ;
Chi, TY ;
Chi, CP .
SHOCK, 1999, 12 (06) :462-467
[6]  
FAYMONVILLE ME, 1991, J THORAC CARDIOV SUR, V102, P309
[7]   Effect of the immunosuppressants FK506 and D-allose on allogenic orthotopic liver transplantation in rats [J].
Hossain, MA ;
Wakabayashi, H ;
Goda, F ;
Kobayashi, S ;
Maeba, T ;
Maeta, H .
TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) :2021-2023
[8]  
Hossain Mohammad Akram, 2003, J Hepatobiliary Pancreat Surg, V10, P218, DOI 10.1007/s00534-002-0785-8
[9]  
Ikebe N, 2000, J PHARMACOL EXP THER, V295, P904
[10]  
Ishii T, 1999, J Hepatobiliary Pancreat Surg, V6, P267, DOI 10.1007/s005340050117